Literature DB >> 10683706

Problem behaviors associated with 15q- Angelman syndrome.

D J Clarke1, G Marston.   

Abstract

Caregivers of persons with Angelman syndrome completed the Aberrant Behavior Checklist and Reiss Screen for Maladaptive Behavior. Seventy-three replies were received, and comparisons were made with other published data. Responses indicated that 15q- Angelman syndrome is associated with such problems as lack of speech, overactivity, restlessness, and eating and sleep problems. Episodes of inappropriate laughter were only reported for 57%, despite being considered a cardinal feature of the syndrome; eating problems (64%) and a fascination with water (68%) were reported more frequently. Overactivity was more of a problem for children; Aberrant Behavior Checklist Factor IV (Hyperactivity) was negatively correlated with age. Scores were mostly lower than for previously studied etiological groups. Therapeutic effort should be put into programs to address these problems.

Entities:  

Mesh:

Year:  2000        PMID: 10683706     DOI: 10.1352/0895-8017(2000)105<0025:PBAWQA>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  19 in total

1.  "You have to sit and explain it all, and explain yourself." Mothers' experiences of support services for their offspring with a rare genetic intellectual disability syndrome.

Authors:  Gemma Maria Griffith; Richard P Hastings; Susie Nash; Michael Petalas; Chris Oliver; Patricia Howlin; Joanna Moss; Jane Petty; Penelope Tunnicliffe
Journal:  J Genet Couns       Date:  2011-01-04       Impact factor: 2.537

2.  A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations.

Authors:  Jennifer K Gentile; Wen-Hann Tan; Lucia T Horowitz; Carlos A Bacino; Steven A Skinner; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Hye-Seung Lee; Trilochan Sahoo; Susan E Waisbren; Lynne M Bird; Sarika U Peters
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

3.  Drowning as a cause of death in Angelman syndrome.

Authors:  Holly A Ishmael; Michael L Begleiter; Merlin G Butler
Journal:  Am J Ment Retard       Date:  2002-01

4.  Angelman syndrome: Mutations influence features in early childhood.

Authors:  Wen-Hann Tan; Carlos A Bacino; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; Sanjeev V Kothare; Hye-Seung Lee; Mark P Nespeca; Sarika U Peters; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

5.  Factor analysis of the aberrant behavior checklist in individuals with autism spectrum disorders.

Authors:  Jason Brinkley; Laura Nations; Ruth K Abramson; Alicia Hall; Harry H Wright; Robin Gabriels; John R Gilbert; Margaret A O Pericak-Vance; Michael L Cuccaro
Journal:  J Autism Dev Disord       Date:  2006-12-21

6.  Brief Report: Challenging Behaviors in Toddlers and Preschoolers with Angelman, Prader-Willi, and Williams Syndromes.

Authors:  Wei Siong Neo; Bridgette L Tonnsen
Journal:  J Autism Dev Disord       Date:  2019-04

7.  Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity.

Authors:  Chris Oliver; Katy Berg; Jo Moss; Kate Arron; Cheryl Burbidge
Journal:  J Autism Dev Disord       Date:  2011-08

Review 8.  Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.

Authors:  Renzo Guerrini; Romeo Carrozzo; Roberta Rinaldi; Paolo Bonanni
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Parent report of stereotyped behaviors, social interaction, and developmental disturbances in individuals with Angelman syndrome.

Authors:  Nicolay Chertkoff Walz
Journal:  J Autism Dev Disord       Date:  2007-05

10.  The pathophysiology of restricted repetitive behavior.

Authors:  Mark Lewis; Soo-Jeong Kim
Journal:  J Neurodev Disord       Date:  2009-06-16       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.